Results 261 to 270 of about 53,329 (292)
Some of the next articles are maybe not open access.

Targeting cancer with phosphodiesterase inhibitors

Expert Opinion on Investigational Drugs, 2009
For many cancers, there has been a shift from management with traditional, nonspecific cytotoxic chemotherapies to treatment with molecule-specific targeted therapies that are used either alone or in combination with traditional chemotherapy and radiation therapy.
Rajkumar, Savai   +6 more
openaire   +2 more sources

Phosphodiesterase Inhibitors in Raynaud's Phenomenon

Annals of Pharmacotherapy, 2006
Objective: TO evaluate the efficacy of the phosphodiesterase type 5 (PDE5) inhibitors in the treatment of Raynaud's phenomenon. Data Sources: Searches of MEDLINE (1966–March 2006) and Web of Science (1980–March 2006) were conducted ...
openaire   +2 more sources

Phosphodiesterase Inhibitors (PDE Inhibitors) and Male Reproduction

2017
The nonspecific PDE inhibitors, particularly the methylxanthines: caffeine, pentoxifylline (PTX), and theophylline, are known to stimulate sperm motility in vitro and have been used to treat sperm prior to insemination. The in vivo effects are less dramatic.
Erma Z, Drobnis, Ajay K, Nangia
openaire   +2 more sources

Phosphodiesterase inhibitors

Baillière's Clinical Anaesthesiology, 1994
J. Boldt, G. Hempelmann
openaire   +1 more source

Phosphodiesterase Inhibitors

2010
R. Hamish McAllister-Williams   +199 more
openaire   +1 more source

Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction

Sexual Medicine Reviews, 2018
Faysal A Yafi   +2 more
exaly  

Home - About - Disclaimer - Privacy